AX-158 has achieved clinical validation through its phase 2a trial for the treatment of patients with mild to moderate plaque ...

Ajay Goel, PhD, AGAF, discusses how the development and validation of novel non-invasive biomarkers can improve early detection and ultimately impact patient outcomes for patients.

Tiziana Life Sciences announces discovery of new immune biomarkers in multiple sclerosis patients treated with nasal foralumab: New York Friday, January 24, 2025, 17:00 Hrs [IST] ...

The NHS stresses all adults with no health issues should aim for less than 5mmol/L (mmol/l stands for millimoles per litre) ...

A collaborative study identifies unique blood plasma biomarkers in pediatric Long Covid patients using AI, achieving a 93% ...

Peptide antigen-associated IgG levels were significantly lower in drug-naïve patients with first episode psychosis compared to control individuals.

The actor’s charitable foundation has just unlocked the key to flagging Parkinson’s disease early, putting us one step closer ...

Firefly Neuroscience, Inc. (“Firefly,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain health outcomes for patients with ...

Juvenile idiopathic arthritis is the most common chronic systemic disease associated with uveitis in childhood. Uveitis occurs in 11–22% of children with juvenile idiopathic arthritis.1 Due to the ...

Neuroblastoma is the most common extracranial solid tumor in children, with nearly 50% of cases diagnosed at an advanced stage, often with metastatic disease.

Shares of Anavex Life Sciences AVXL, a clinical-stage biotech making medicines to treat central nervous system (CNS) diseases ...

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...